# A Study in Healthy People to Compare Two Different Sifrol® Tablets

> **NCT06457204** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pramipexole manufactured in Ingelheim
- **DRUG:** Pramipexole manufactured in Ennigerloh

## Key facts

- **NCT ID:** NCT06457204
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-02
- **Primary completion:** 2024-08-12
- **Final completion:** 2024-08-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06457204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06457204, "A Study in Healthy People to Compare Two Different Sifrol® Tablets". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06457204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*